MAPT and Alzheimer disease: Consequently, research efforts are increasingly focused on identifying the underlying mechanisms of AD, such as tau protein abnormalities, β-amyloid accumulation, inflammation, acetylcholinesterase activation (cholinergic dysfunction), and oxidative stress, and the development of effective therapies (Breijyeh and Karaman, 2020; Meng-zhen et al., 2022).